August 15, 2022
A key health ministry advisory committee will discuss whether to recommend approval for a batch of new drugs and indications including Eli Lilly’s GIP/GLP-1 receptor agonist tirzepatide at an upcoming meeting on August 25. The Pharmaceutical Affairs and Food Sanitation...read more